Volatile anesthetic-induced cardiac preconditioning.

Area of Science:

• Cardiology
• Anesthesiology
• Molecular Biology

Background:

• Pharmacological preconditioning with volatile anesthetics, or anesthetic-induced preconditioning (APC), offers cardiac protection against ischemia-reperfusion injury.
• The mechanisms of APC share similarities with endogenous ischemic preconditioning.
• Understanding APC is crucial for managing cardiac events during and after anesthesia.

Purpose of the Study:

• To review recent evidence on the cellular and molecular mechanisms of anesthetic-induced preconditioning.
• To highlight the roles of mitochondria, reactive oxygen species, and K(ATP) channels in APC.
• To discuss current concepts and controversies surrounding K(ATP) channel involvement in APC.

Main Methods:

• Literature review of recent accumulated evidence.
• Analysis of studies investigating cardioprotective signaling pathways.
• Discussion of current concepts and controversies in the field.

Main Results:

• Mitochondria, reactive oxygen species, and K(ATP) channels are central to cardioprotective signaling by volatile anesthetics.
• Evidence suggests APC mimics endogenous ischemic preconditioning mechanisms.
• Specific roles of mitochondrial versus sarcolemmal K(ATP) channels in APC remain under investigation.

Conclusions:

• Volatile anesthetics induce cardiac protection through mechanisms involving mitochondria, ROS, and K(ATP) channels.
• APC represents a significant pharmacological approach to cardioprotection.
• Further research is needed to fully elucidate the precise roles of different K(ATP) channel subtypes in APC.